Cargando…
TLR9 Agonist Protects Mice from Radiation-Induced Gastrointestinal Syndrome
PURPOSE: Radiation-induced gastrointestinal syndrome (RIGS) is due to the clonogenic loss of crypt cells and villi depopulation, resulting in disruption of mucosal barrier, bacterial invasion, inflammation and sepsis. Intestinal macrophages could recognize invading bacterial DNA via TLR9 receptors a...
Autores principales: | Saha, Subhrajit, Bhanja, Payel, Liu, Laibin, Alfieri, Alan A., Yu, Dong, Kandimalla, Ekambar R., Agrawal, Sudhir, Guha, Chandan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251576/ https://www.ncbi.nlm.nih.gov/pubmed/22238604 http://dx.doi.org/10.1371/journal.pone.0029357 |
Ejemplares similares
-
An In Situ Autologous Tumor Vaccination with Combined Radiation Therapy and TLR9 Agonist Therapy
por: Zhang, Huagang, et al.
Publicado: (2012) -
Bone Marrow Stromal Cell Transplantation Mitigates Radiation-Induced Gastrointestinal Syndrome in Mice
por: Saha, Subhrajit, et al.
Publicado: (2011) -
Protective Role of R-spondin1, an Intestinal Stem Cell Growth Factor, against Radiation-Induced Gastrointestinal Syndrome in Mice
por: Bhanja, Payel, et al.
Publicado: (2009) -
Low intensity focused ultrasound (LOFU) modulates unfolded protein response and sensitizes prostate cancer to 17AAG
por: Saha, Subhrajit, et al.
Publicado: (2014) -
Novel oligodeoxynucleotide agonists of TLR9 containing N(3)-Me-dC or N(1)-Me-dG modifications
por: Putta, Mallikarjuna Reddy, et al.
Publicado: (2006)